Orthofix Medical Inc. (OFIX)

Orthofix Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-126.48	-151.4	-19.75	-38.38	2.52	-28.46
Depreciation & Amortization	55.26	53.06	29.02	29.6	30.55	24.7
Share-Based Compensation	31.49	35.71	18.44	15.43	16.21	21.54
Other Operating Activities	9.41	16.87	-39.25	11.82	25	14.26
Operating Cash Flow	-30.33	-45.75	-11.54	18.48	74.27	32.03
Operating Cash Flow Growth	-	-	-	-75.13%	131.86%	-35.83%
Capital Expenditures	-61.03	-62.05	-23.16	-19.59	-17.09	-20.52
Acquisitions	0	29.42	-1.5	0	-25.24	-2.4
Change in Investments	0	0	0	-2.17	-10	0
Other Investing Activities	-0.05	-0.5	0.13	-1.25	-	-
Investing Cash Flow	-61.08	-33.13	-24.53	-23.01	-52.33	-22.92
Share Issuance / Repurchase	5.13	5.13	4.34	8.82	7.6	11.55
Debt Issued / Paid	70.93	65.59	-2.69	-1.49	-1.86	-3.39
Other Financing Activities	-5.27	-5.4	-1.73	-10.96	-2.49	-18.85
Financing Cash Flow	70.79	65.32	-0.08	-3.62	3.25	-10.69
Exchange Rate Effect	0.11	0.62	-1	-0.82	1.24	-0.21
Net Cash Flow	-20.5	-12.94	-37.15	-8.97	26.42	-1.79
Free Cash Flow	-91.36	-107.8	-34.7	-1.12	57.18	11.51
Free Cash Flow Growth	-	-	-	-	396.81%	-66.80%
Free Cash Flow Margin	-12.02%	-14.44%	-7.53%	-0.24%	14.06%	2.50%
Free Cash Flow Per Share	-2.42	-2.94	-1.73	-0.06	2.97	0.61

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).